Tag: Intensive Care
New Models Predict Risk for Ventilation, Death From COVID-19
Age not a predictor of which hospitalized COVID-19 patients will require ventilation
IL-6 Receptor Antagonists Benefit Critically Ill With COVID-19
Improved outcomes, including more organ support-free days, reduced mortality, seen with tocilizumab, sarilumab
One in 10 Continue Opioid Use Two Years After ICU Admission
Opioid use peaks in the first quarter after admission and declines continuously, but does not reach preadmission baseline over 24 months
Methylprednisolone Added to IVIG May Cut Fever in MIS-C
IV immunoglobulins plus methylprednisolone associated with lower risk for treatment failure compared with immunoglobulins alone
Transient Return of Cardiac Activity ID’d After Pulselessness
Based on waveform analysis, cardiac activity occurred in 14 percent of patients after planned withdrawal of life-sustaining measures
Lower Oxygen Target Does Not Cut Deaths in Respiratory Failure
Findings show no difference in mortality for lower-, higher-oxygenation target in adults with acute hypoxemic respiratory failure
Tocilizumab Does Not Improve Outcomes in Severe COVID-19
Tocilizumab plus standard care no better for improving clinical outcomes at 15 days and may increase mortality
Mortality Decreased for COVID-19 ICU Patients Over Time
Mortality decreased from 43.5 to 19.2 percent between first and last 15-day periods; no change seen in other patient factors
For COVID-19 ICU Patients, Death Linked to COVID-19 ICU Strain
Mortality increased when COVID-19 ICU demand was >75 to 100 percent for patients treated in COVID-19 ICU
Men More Likely to Test Positive for SARS-CoV-2, Die From COVID-19
During their hospital course, more men than women experience pulmonary and extrapulmonary complications
